198 related articles for article (PubMed ID: 28500264)
21. Piperlonguminine a new mitochondrial aldehyde dehydrogenase activator protects the heart from ischemia/reperfusion injury.
Yoval-Sánchez B; Calleja LF; de la Luz Hernández-Esquivel M; Rodríguez-Zavala JS
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129684. PubMed ID: 32679250
[TBL] [Abstract][Full Text] [Related]
22. Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation.
Xiong W; Zhou R; Qu Y; Yang Y; Wang Z; Song N; Liang R; Qian J
Biomed Pharmacother; 2021 Sep; 141():111853. PubMed ID: 34237593
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
Nuñez RE; Javadov S; Escobales N
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
[TBL] [Abstract][Full Text] [Related]
24. Autophagy in ALDH2-elicited cardioprotection against ischemic heart disease: slayer or savior?
Zhang Y; Ren J
Autophagy; 2010 Nov; 6(8):1212-3. PubMed ID: 20935489
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2.
Chumanevich A; Wedman P; Oskeritzian CA
Mediators Inflamm; 2016; 2016():1503206. PubMed ID: 26884643
[TBL] [Abstract][Full Text] [Related]
26. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
Hashikawa-Hobara N; Chan NY; Levi R
J Pharmacol Exp Ther; 2012 Jan; 340(1):185-91. PubMed ID: 22011436
[TBL] [Abstract][Full Text] [Related]
27. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
28. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
Rana A; Sharma S
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
[TBL] [Abstract][Full Text] [Related]
30. Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions.
Wanka H; Staar D; Lutze P; Peters B; Hildebrandt J; Beck T; Bäumgen I; Albers A; Krieg T; Zimmermann K; Sczodrok J; Schäfer S; Hoffmann S; Peters J
J Mol Med (Berl); 2016 Jan; 94(1):61-9. PubMed ID: 26256830
[TBL] [Abstract][Full Text] [Related]
31. Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
Dai W; Kloner RA
Postgrad Med; 2011 Mar; 123(2):49-55. PubMed ID: 21474893
[TBL] [Abstract][Full Text] [Related]
32. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
33. Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility.
Li C; Sun W; Gu C; Yang Z; Quan N; Yang J; Shi Z; Yu L; Ma H
Theranostics; 2018; 8(4):1027-1041. PubMed ID: 29463997
[TBL] [Abstract][Full Text] [Related]
34. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.
Parikh V; Singh M
Pharmacol Res; 1999 Aug; 40(2):129-37. PubMed ID: 10433871
[TBL] [Abstract][Full Text] [Related]
35. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.
Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV
J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective role of sphingosine-1-phosphate.
Knapp M
J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
[TBL] [Abstract][Full Text] [Related]
37. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
38. Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance.
Gu C; Xing Y; Jiang L; Chen M; Xu M; Yin Y; Li C; Yang Z; Yu L; Ma H
PLoS One; 2013; 8(9):e74050. PubMed ID: 24040162
[TBL] [Abstract][Full Text] [Related]
39. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2.
Churchill EN; Disatnik MH; Mochly-Rosen D
J Mol Cell Cardiol; 2009 Feb; 46(2):278-84. PubMed ID: 18983847
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
